ImageneBio, Inc. (IMA)

ImageneBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	6.02	12.12	15.32
Short-Term Investments	-	-	10.15
Cash & Short-Term Investments	6.02	12.12	25.47
Cash Growth	-	-52.43%	-
Other Receivables	0.1	0.08	0.22
Receivables	0.1	0.08	0.22
Prepaid Expenses	0.1	0.21	0.2
Other Current Assets	6.36	0.06	-
Total Current Assets	12.58	12.47	25.9
Property, Plant & Equipment	0.4	0.56	4.28
Other Long-Term Assets	0.07	2.9	1.07
Total Assets	19.13	15.92	31.25
Accounts Payable	6.55	5.29	5.88
Accrued Expenses	4.41	3.46	3.13
Short-Term Debt	22.89	7.5	-
Current Portion of Leases	0.26	0.31	0.42
Current Unearned Revenue	-	0.65	0.07
Total Current Liabilities	34.11	17.21	9.49
Long-Term Leases	0.12	0.24	0.57
Long-Term Unearned Revenue	-	-	0.07
Total Liabilities	34.24	17.45	10.13
Common Stock	0.02	0.02	0.01
Additional Paid-In Capital	-	2.14	-
Retained Earnings	-197.52	-179.9	-143.33
Comprehensive Income & Other	-1.82	-1.79	-1.75
Total Common Equity	-199.32	-179.53	-145.08
Shareholders' Equity	-15.11	-1.53	21.12
Total Liabilities & Equity	19.13	15.92	31.25
Total Debt	23.27	8.05	0.98
Net Cash (Debt)	-17.25	4.07	24.49
Net Cash Growth	-	-83.38%	-
Net Cash Per Share	-0.04	0.01	0.08
Filing Date Shares Outstanding	11.18	462.11	320.91
Total Common Shares Outstanding	462.68	462.11	320.91
Working Capital	-21.53	-4.74	16.41
Book Value Per Share	-0.43	-0.39	-0.45
Tangible Book Value	-199.32	-179.53	-145.08
Tangible Book Value Per Share	-0.43	-0.39	-0.45
Machinery	-	0.11	3.19
Leasehold Improvements	-	0.23	3.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q